Columbia University

Technology Ventures

TRx and CTV Translational Therapeutics Seminar: Venture Capital- The Science (and Art) of Investing

May 22, 2017
Stephanie Stehman, PhD
Irving Institute (PH10-405)
622 W. 168th Street, 10th floor
New York, NY

The TRx pilot award is designed to provide education, mentorship, and funding to accelerate early-stage therapy discovery towards the clinic. The Translational Therapeutics Seminar Series is a 6-part series which will include speakers with varying perspectives on the drug development process, ranging from an academic investigator’s experiences to an industry investor’s perspective. 

Part three of the series features Dr. Stephanie Stehman, Senior Associate at Osage University Partners.

For more information, please contact Maria Rahmany at